SHARA MILLS: Open Payments
NPI 1023350048 · MORGANFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 51 payments from 13 companies in 2025. Trend: 2023 $814 · 2024 $1,018 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $221 |
| AstraZeneca Pharmaceuticals LP | 6 | $197 |
| PFIZER INC. | 12 | $151 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Novo Nordisk Inc | 3 | $50 |
| Amgen Inc. | 3 | $49 |
| Insulet Corporation | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: AIRSUPRA, UBRELVY, VRAYLAR, NURTEC ODT, REXULTI, ELIQUIS, Ozempic, QULIPTA.
Industry payments across KY — which companies pay providers there.
